Viewing Study NCT01481220

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2026-02-24 @ 1:46 AM
Study NCT ID: NCT01481220
Status: COMPLETED
Last Update Posted: 2013-05-03
First Post: 2011-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)
Sponsor: Nordic MDS Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
None Thrombocytopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelodysplastic syndrome View
None azacitidine View
None Eltrombopag View
None Thrombopoietin-receptor agonist View
None Thrombocytopenia View
None Transfusion dependency View
None Safety study View